[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR890008107A - 2-thiohydantoin derivative and preparation method - Google Patents

2-thiohydantoin derivative and preparation method Download PDF

Info

Publication number
KR890008107A
KR890008107A KR870012361A KR870012361A KR890008107A KR 890008107 A KR890008107 A KR 890008107A KR 870012361 A KR870012361 A KR 870012361A KR 870012361 A KR870012361 A KR 870012361A KR 890008107 A KR890008107 A KR 890008107A
Authority
KR
South Korea
Prior art keywords
methyl
thiohydantoin
formula
alkyl
compound
Prior art date
Application number
KR870012361A
Other languages
Korean (ko)
Other versions
KR910006129B1 (en
Inventor
김충섭
서정진
이봉용
김창섭
김재규
이종옥
박근희
Original Assignee
홍병규
주식회사 유한양행
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 홍병규, 주식회사 유한양행 filed Critical 홍병규
Priority to KR1019870012361A priority Critical patent/KR910006129B1/en
Publication of KR890008107A publication Critical patent/KR890008107A/en
Application granted granted Critical
Publication of KR910006129B1 publication Critical patent/KR910006129B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86Oxygen and sulfur atoms, e.g. thiohydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음No content

Description

2-티오히단토인 유도체와 제조방법2-thiohydantoin derivative and preparation method

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (28)

항 경련 효과를 갖는 하기 일반식(Ⅰ)화합물.The following general formula (I) compound having an anticonvulsant effect. 상기 구조식(Ⅰ)에서, R1은 알콕시알킬, 디알콕시아킬, (1,3-디옥소란-2-일) 알킬, (1,3-디옥소란-4-메틸-2-일)알킬, (1,3-디옥소란-2-메틸-2-일) 알킬, (1,3-벤조디옥솔-2-일) 알킬 도는 벤젠핵에 알킬, 알콕시 또는 할로겐이 치환된 (1,3-벤조디옥솔-2-일) 알킬기이며 ; R2는 수소, 알킬 또는 알릴기이며 ; R3와 R4는 수소 또는 알킬기이고 이들 치환기가 서로 같거나 다르게 치환되어 있다.In formula (I), R 1 is alkoxyalkyl, dialkoxyacyl, (1,3-dioxolan-2-yl) alkyl, (1,3-dioxolane-4-methyl-2-yl) alkyl , (1,3-dioxolane-2-methyl-2-yl) alkyl, (1,3-benzodioxol-2-yl) alkyl or benzene nucleus substituted by alkyl, alkoxy or halogen (1,3 -Benzodioxol-2-yl) alkyl group; R 2 is hydrogen, alkyl or allyl group; R 3 and R 4 are hydrogen or an alkyl group and these substituents are the same as or different from each other. 제 1 항에 있어서 구조식(Ⅰ) 화합물을 주성분으로 하여 약제학적으로 허용되는 부형제 또는 용매를 사용하여, 경련을 예방, 억제 또는 치료할 목적을 약리학적 유효량을 함유하는 약제학적인 조면.A pharmaceutical groyne according to claim 1 which contains a pharmacologically effective amount for the purpose of preventing, inhibiting or treating convulsions using a pharmaceutically acceptable excipient or solvent mainly comprising the compound of formula (I). 1-(2,2-디메톡시) 에틸-3-메틸-2-티오히단토인.1- (2,2-dimethoxy) ethyl-3-methyl-2-thiohydantoin. 1-(2,2-디메톡시) 에틸-3-에틸-2-티오히단토인.1- (2,2-dimethoxy) ethyl-3-ethyl-2-thiohydantoin. 1-(2,2-디메톡시) 에틸-3-알릴-2-티오히단토인.1- (2,2-dimethoxy) ethyl-3-allyl-2-thiohydantoin. 1-(2,2-디메톡시) 에틸-3-메틸-5,5-디메틸-2-티오히단토인.1- (2,2-dimethoxy) ethyl-3-methyl-5,5-dimethyl-2-thiohydantoin. 1-(2-메톡시에틸)-3-메틸-2-티오히단토인.1- (2-methoxyethyl) -3-methyl-2-thiohydantoin. 1-(2-메톡시에틸)-3-알릴-2-티오히단토인.1- (2-methoxyethyl) -3-allyl-2-thiohydantoin. 1-(3,3-디메톡시)프로필-3-메틸-2-티오히단토인.1- (3,3-dimethoxy) propyl-3-methyl-2-thiohydantoin. 1-(2,2-디메톡시) 에틸-3-메틸-2-티오히단토인.1- (2,2-dimethoxy) ethyl-3-methyl-2-thiohydantoin. 1-(2-(1,3-디옥소란-2-일)에틸]-3-메틸-2-티오히단토인.1- (2- (1,3-dioxolan-2-yl) ethyl] -3-methyl-2-thiohydantoin. 1-(1,3-디옥소란-2-일)메틸-2-티오히단토인.1- (1,3-dioxolan-2-yl) methyl-2-thiohydantoin. 1-(1,3-디옥소란-2-메틸-2-일)메틸-2-티오히단토인.1- (1,3-dioxolane-2-methyl-2-yl) methyl-2-thiohydantoin. 1-(1,3-디옥소란-4-메틸-2-일)메틸-2-티오히단토인.1- (1,3-dioxoran-4-methyl-2-yl) methyl-2-thiohydantoin. 1-(1,3-벤조디옥솔-2-일)메틸-3-메틸-2-티오히단토인.1- (1,3-benzodioxol-2-yl) methyl-3-methyl-2-thiohydantoin. 1-(2,2-디메톡시)에틸-2-티오히단토인.1- (2,2-dimethoxy) ethyl-2-thiohydantoin. 1-(2,2-디메톡시)에틸-5-메틸-2-티오히단토인.1- (2,2-dimethoxy) ethyl-5-methyl-2-thiohydantoin. 1-(2,2-디메톡시)에틸-5,5-디메틸-2-티오히단토인.1- (2,2-dimethoxy) ethyl-5,5-dimethyl-2-thiohydantoin. 1-(1,3-디옥소란-2-일)-메틸-2-티오히단토인.1- (1,3-dioxolan-2-yl) -methyl-2-thiohydantoin. 1-(1,3-벤조디옥솔-2-일)메틸-2-티오히단토인.1- (1,3-benzodioxol-2-yl) methyl-2-thiohydantoin. 1-(1,3-벤조디옥솔-5-메틸-2-일)메틸-2-티오히단토인.1- (1,3-benzodioxol-5-methyl-2-yl) methyl-2-thiohydantoin. 1-(1,3-벤조디옥솔-4-메톡시-2-일)메틸-2-티오히단토인.1- (1,3-benzodioxol-4-methoxy-2-yl) methyl-2-thiohydantoin. 1-(1,3-벤조디옥솔-5-클로로-2-일)메틸-2-티오히단토인.1- (1,3-benzodioxol-5-chloro-2-yl) methyl-2-thiohydantoin. 1-(1,3-벤조디옥솔-5-풀루오로-2-일)메틸-2-티오히단토인.1- (1,3-benzodioxol-5- pulluro-2-yl) methyl-2-thiohydantoin. 아래 구조식(Ⅰ) 화합물을 구조식(Ⅱ)와 (Ⅲ)화합물을 반응시켜 제조하는 방법.A method for preparing a compound of formula (I) below by reacting a compound of formula (II) with (III) 상기구조식(Ⅰ)에서, R1은 알콕시알킬, 디알콕시알킬, (1,3-디옥소란-2-일) 알킬, (1,3-디옥소소란-2-메틸-2-일) 알킬, (1,3-디옥소란-4-메틸-2-일) 알킬, (1,3-벤조디옥솔-2-일) 알킬 또는 벤젠핵에 알킬, 알콕시 또는 할로겐이 치환된 (1,3-벤조디옥솔-2-일) 알킬이며 ; R2는 수소, 알킬 또는 알릴기이고 ; R3와 R4는 수소 또는 알킬기를 나타내며, 서로 같거나 서로 다르게 치환되어 있다. 상기 구조식(Ⅱ)에서 R1, R3및 R4는 구조식(Ⅰ)에서 정의한 바와같고, R5는 탄소수 1∼4개의 알킬 또는 벤질이며, 구조식(Ⅲ)에서 R2는 수소를 제외하고 상기 구조식(Ⅰ)에서 정의한 바와 같다.In the above formula (I), R 1 is alkoxyalkyl, dialkoxyalkyl, (1,3-dioxolan-2-yl) alkyl, (1,3-dioxoranan-2-methyl-2-yl) alkyl (1,3 with alkyl, alkoxy or halogen substituted in (1,3-dioxoran-4-methyl-2-yl) alkyl, (1,3-benzodioxol-2-yl) alkyl or benzene nucleus -Benzodioxol-2-yl) alkyl; R 2 is hydrogen, alkyl or allyl group; R 3 and R 4 represent hydrogen or an alkyl group, and are the same as or different from each other. In formula (II), R 1 , R 3 and R 4 are as defined in formula (I), R 5 is alkyl or benzyl having 1 to 4 carbon atoms, and in formula (III), R 2 except hydrogen As defined in Structural Formula (I). 제 25 항의 구조식(Ⅰ) 화합물에서 R2가 수소인 화합물을 구조식(Ⅱ) 글리신 에틸에스테르 유도체를 벤조일이소티오시아네이트와 반응시켜 구조식(Ⅳ) N-벤조일 티오카바모일 글리신 에스테르 유도체를 합성하고 트리에틸아민 또는 피리딘과 같은 염기성 용매에서 환화하여 구조식(Ⅰ) 화합물을 제조하는 방법.A compound wherein R 2 is hydrogen in the compound of formula (I) according to claim 25 is synthesized by reacting a compound of formula (II) glycine ethyl ester derivative with benzoylisothiocyanate to formulate (IV) N-benzoyl thiocarbamoyl glycine ester derivative and A process for preparing the compound of formula (I) by cyclization in a basic solvent such as ethylamine or pyridine. 제 26 항에 있어서, 반응이 구조식(Ⅰ)의 3위치 질소원자에 벤조일기가 치환된 구조식(Ⅴ)의 화합물로 종결된 경우, 구조식(Ⅴ)화합물을 분리하고 수산화나트륨 수용액에서 가수분해하여 구조식(Ⅰ) 화합물을 제조하는 방법.27. The compound of claim 26, wherein the reaction is terminated with a compound of formula (V) in which a benzoyl group is substituted for a 3-position nitrogen atom of formula (I), the compound of formula (V) is separated and hydrolyzed in aqueous sodium hydroxide solution I) A method for preparing a compound. 구조식(Ⅰ) 화합물의 1위치의 질소원자에 아세탈알킬기가 치환된 경우, 산촉매 존재하에서 알콜과 아세탈 교환반응을 실시하여 해당하는 알콜의 아세탈 유도체를 제조하는 방법.A method for producing an acetal derivative of an alcohol by carrying out an acetal exchange reaction with an alcohol in the presence of an acid catalyst when the nitrogen atom at the 1 position of the compound of formula (I) is substituted. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019870012361A 1987-11-04 1987-11-04 2-thio hidantoine derivative KR910006129B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019870012361A KR910006129B1 (en) 1987-11-04 1987-11-04 2-thio hidantoine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019870012361A KR910006129B1 (en) 1987-11-04 1987-11-04 2-thio hidantoine derivative

Publications (2)

Publication Number Publication Date
KR890008107A true KR890008107A (en) 1989-07-06
KR910006129B1 KR910006129B1 (en) 1991-08-13

Family

ID=19265756

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870012361A KR910006129B1 (en) 1987-11-04 1987-11-04 2-thio hidantoine derivative

Country Status (1)

Country Link
KR (1) KR910006129B1 (en)

Also Published As

Publication number Publication date
KR910006129B1 (en) 1991-08-13

Similar Documents

Publication Publication Date Title
KR850006939A (en) Method for preparing acyl tripeptides
KR840001156A (en) Method for preparing benzimidazole derivatives
KR880012526A (en) l-phenyl-3-naphthalenyloxypropanamine
KR840005103A (en) Method for preparing 1-aryloxy-2,3,4,5-tetrahydro-3-benzazine
KR850001905A (en) Method for preparing benzocyclo alkan derivatives
KR840000563A (en) Process for preparing cefem compound
PT84881A (en) Process for the preparation of 4(5)-substituted imidazole derivatives
KR910000751A (en) Cefem compound and preparation method thereof
KR890013007A (en) Benzodioxole derivatives and preparation method thereof
KR860700251A (en) Novel tricyclic or tetracyclic compounds and methods for preparing the salts thereof
KR880701233A (en) New biphenyl derivatives and methods for their preparation and uses
KR870007167A (en) Method for preparing phenyl naphthyridine
KR840004757A (en) Method for preparing cephalosporin derivative
KR860001073A (en) Method for preparing imidazoline
KR890008107A (en) 2-thiohydantoin derivative and preparation method
KR890002103A (en) Piperidine Derivatives, Preparations and Dorjival 38
KR920002517A (en) Benzhydryl derivatives having a calmodulin inhibitory property and preparation method thereof
KR830007484A (en) Method for preparing novel cinnamoyl-cinnamic acid derivatives
KR890701576A (en) 2,5,6,7-tetranol-4,8-inter-m-phenylene PGI₂ derivatives and preparation and use thereof
KR860003212A (en) Method for preparing 2-pyridine-thiol derivatives and acid addition salts thereof
KR910004585A (en) 1,5-benzothiazepine derivative and preparation method thereof
KR910011777A (en) Pyrrolealdehyde Derivatives, Preparation Methods thereof, and Pharmaceutical Compositions Containing the Compounds
KR880012544A (en) Benzenesulfonamide Derivatives and Preparation Methods Thereof
KR870003114A (en) Tetrahydroisoquinoline derivatives
US4045567A (en) 2-Alkyl-5-thiazole-carboxylic acid derivatives in hypolipemiant compositions

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19980720

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee